Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)

Carcinoma of Unknown Primary Site

(2015) Gauri Varadhachary   JAMA Oncology

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site

(2015) Jeffrey S. Ross et al.   JAMA Oncology

Cancer of Unknown Primary Site

(2014) Gauri R. Varadhachary et al.   NEW ENGLAND JOURNAL OF MEDICINE

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

(2013) G. R. Varadhachary et al.   International Journal of Clinical Oncology

Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non–small cell lung cancer

(2013) Wilfried E. E. Eberhardt et al.   INVESTIGATIONAL NEW DRUGS

Molecular Profiling Diagnosis in Unknown Primary Cancer: Accuracy and Ability to Complement Standard Pathology

(2013) F. Anthony Greco et al.   JNCI-Journal of the National Cancer Institute

Everolimus in combination with paclitaxel and carboplatin in patients with metastatic melanoma

(2013) Ralph J. Hauke et al.   MELANOMA RESEARCH

Multisite Validation Study to Determine Performance Characteristics of a 92-Gene Molecular Cancer Classifier

(2012) S. E. Kerr et al.   CLINICAL CANCER RESEARCH

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial

(2012) M. Gross-Goupil et al.   EUROPEAN JOURNAL OF CANCER

Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute

(2012) John D. Hainsworth et al.   JOURNAL OF CLINICAL ONCOLOGY

Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial

(2012) Shernan G. Holtan et al.   PLoS One

A Retrospective Study of Treatment Outcomes in Patients With Carcinoma of Unknown Primary Site and a Colorectal Cancer Molecular Profile

(2011) John D. Hainsworth et al.   Clinical Colorectal Cancer

Validation and Reproducibility of a Microarray-Based Gene Expression Test for Tumor Identification in Formalin-Fixed, Paraffin-Embedded Specimens

(2011) Raji Pillai et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor Classification

(2011) Mark G. Erlander et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Paclitaxel/Carboplatin/Etoposide Versus Gemcitabine/Irinotecan in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site

(2010) John D. Hainsworth et al.   CANCER JOURNAL

Multicenter Validation of a 1,550-Gene Expression Profile for Identification of Tumor Tissue of Origin

(2009) Federico A. Monzon et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Profiling of Carcinoma of Unknown Primary and Correlation With Clinical Evaluation

(2008) Gauri R. Varadhachary et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression Profiling to Identify the Histogenetic Origin of Metastatic Adenocarcinomas of Unknown Primary

(2008) Hugo M. Horlings et al.   JOURNAL OF CLINICAL ONCOLOGY

Carcinoma of unknown primary with a colon-cancer profile—changing paradigm and emerging definitions

(2008) Gauri R Varadhachary et al.   LANCET ONCOLOGY

Interlaboratory Performance of a Microarray-Based Gene Expression Test to Determine Tissue of Origin in Poorly Differentiated and Undifferentiated Cancers

(2007) Catherine I. Dumur et al.   JOURNAL OF MOLECULAR DIAGNOSTICS